Skip to main content

Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach

Sarin, Navin, Engel, Florian, Rothweiler, Florian, Cinatl, Jindrich, Michaelis, Martin, Frötschl, Roland, Fröhlich, Holger, Kalayda, Ganna V (2018) Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. International Journal of Molecular Sciences, 19 (3). pp. 767-785. ISSN 1422-0067. (doi:10.3390/ijms19030767) (KAR id:66690)

PDF Publisher pdf
Language: English

Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.
Download (1MB) Preview
Official URL


The major obstacle in the clinical use of the antitumor drug cisplatin is inherent and

for a systems pharmacology approach to understand a whole cell’s reaction to the drug. In this

cells and their cisplatin-resistant sub-line A549rCDDP2000 was screened with a whole genome array

and without a previously defined hypothesis HRas, MAPK14 (p38), CCL2, DOK1 and PTK2B

further validated on transcriptome (qRT-PCR) and proteome (Western blot) level to select candidates

of resistance-associated signalling alterations describing differential gene and protein expression

between cisplatin-sensitive and -resistant cells in reaction to cisplatin exposure.

Item Type: Article
DOI/Identification number: 10.3390/ijms19030767
Uncontrolled keywords: cisplatin resistance; cellular signalling; HRas; p38; CCL2; DOK1; PTK2B; JNK3
Divisions: Faculties > Sciences > School of Biosciences
Depositing User: Martin Michaelis
Date Deposited: 11 Apr 2018 14:16 UTC
Last Modified: 29 May 2019 20:27 UTC
Resource URI: (The current URI for this page, for reference purposes)
Michaelis, Martin:
  • Depositors only (login required):


Downloads per month over past year